Renal Pelvic Denervation Pilot Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

March 2, 2029

Conditions
Uncontrolled Hypertension
Interventions
DEVICE

RPD

Renal Pelvic Denervation

DRUG

Active hypertension medical therapy

Prespecified two medication regimen for control of hypertension

Sponsors
All Listed Sponsors
collaborator

RQM+

INDUSTRY

collaborator

Dabl Ltd

UNKNOWN

collaborator

Medical Labs Memphis - MLM

UNKNOWN

lead

Verve Medical, Inc

INDUSTRY

NCT07005050 - Renal Pelvic Denervation Pilot Trial | Biotech Hunter | Biotech Hunter